These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 7528450)
1. Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer. Willemse PH; Boonstra H; de Vries EG Semin Oncol; 1994 Dec; 21(6 Suppl 16):44-50. PubMed ID: 7528450 [No Abstract] [Full Text] [Related]
2. Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy. Fisher DC; Peters WP Curr Opin Hematol; 1994 May; 1(3):221-7. PubMed ID: 9371286 [TBL] [Abstract][Full Text] [Related]
3. Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis. Peters BG; Adkins DR; Harrison BR; Velasquez WS; Dunphy FR; Petruska PJ; Bowers CE; Niemeyer R; McIntyre W; Vrahnos D; Auberry SE; Spitzer G Bone Marrow Transplant; 1996 Jul; 18(1):93-102. PubMed ID: 8832001 [TBL] [Abstract][Full Text] [Related]
4. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial. Bernstein SH; Fay JP; Christiansen NP; Pinero L; Shah D; Stephan M; Herzig GP Clin Cancer Res; 1997 Sep; 3(9):1519-26. PubMed ID: 9815838 [TBL] [Abstract][Full Text] [Related]
6. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135 [No Abstract] [Full Text] [Related]
7. A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy. Sosman JA; Stiff PJ; Bayer RA; Peliska J; Peace DJ; Loutfi S; Stock W; Oldenburg D; Unverzagt K; Bender J Bone Marrow Transplant; 1995 Nov; 16(5):655-61. PubMed ID: 8547862 [TBL] [Abstract][Full Text] [Related]
15. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease. de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor and marrow transplantation. Sauter C N Engl J Med; 1988 Sep; 319(13):870-1. PubMed ID: 3045556 [No Abstract] [Full Text] [Related]
17. Recombinant human erythropoietin in combination with other hematopoietic cytokines in attenuating chemotherapy-induced multilineage myelosuppression: brief communication. Vadhan-Raj S Semin Hematol; 1996 Jan; 33(1 Suppl 1):16-8. PubMed ID: 8714611 [No Abstract] [Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor in the treatment of small cell lung cancer. Wolf M; Klausmann M; Havemann K Semin Oncol; 1994 Dec; 21(6 Suppl 16):51-6. PubMed ID: 7801147 [No Abstract] [Full Text] [Related]
19. Bone marrow failure and hematopoietic growth factors. Douer D Isr J Med Sci; 1989 Apr; 25(4):183-5. PubMed ID: 2468629 [No Abstract] [Full Text] [Related]
20. High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: preliminary report of a new strategy. Yen ML; Chen YC; Lin MT; Liu MC; Tang JL; Wang CH; Hsieh CY Transplant Proc; 1992 Aug; 24(4):1533-5. PubMed ID: 1496649 [No Abstract] [Full Text] [Related] [Next] [New Search]